Oscar Juan-Vidal - Hospital Universitari i Politécnic La Fe

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 56 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Five-year Outcomes with First-Line Nivolumab Plus Ipilimumab with 2 Cycles of Chemotherapy Versus 4 Cycles of Chemotherapy Alone in Patients with Metastatic Non-Small Cell Lung Cancer in the Randomized CheckMate 9LA Trial

Martin Reck,Tudor-Eliade Ciuleanu,Michael Schenker,Stephanie Bordenave,Manuel Cobo,Oscar Juan-Vidal,Niels Reinmuth,Eduardo Richardet,Enriqueta Felip,Juliana Menezes,Ying Cheng,Hideaki Mizutani,Bogdan Zurawski,Aurelia Alexandru,David P. Carbone,Shun Lu,Thomas John, Takekazu Aoyama, Diederik J. Grootendorst,Nan Hu, Laura J. Eccles, Luis G. Paz-Ares

EUROPEAN JOURNAL OF CANCER (2024)

引用0浏览0WOS引用

Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer

Edurne Arriola,Javier de Castro,Rosario García-Campelo,Beatriz Bernárdez,Reyes Bernabé,Jordi Bruna, Manuel Dómine,Dolores Isla,Óscar Juan-Vidal,Teresa López-Fernández,Ernest Nadal,Delvys Rodríguez-Abreu, María Vares, Úrsula Asensio, Luis F. García,Enriqueta Felip

Clinical drug investigationno. 8 (2024): 553-576

引用0浏览0WOS引用

The S-REAL Study: Spanish Real-World Data on Unresectable Stage III NSCLC Patients Treated with Durvalumab after Chemoradiotherapy

Ana Gómez Rueda,Álvaro Taus, Álvarez,Reyes Bernabé-Caro,Luis Chara,Marta López-Brea,Laia Vilà,Maria Ángeles Sala González, Anabel del Barrio Díaz Aldagalán, Beatriz Esteban Herrera,Rafael López Castro,Ruth Álvarez Cabellos,Marta Doménech,Sandra Falagan, Alberto Moreno Vega,Carlos Aguado,Andrés Barba, Maria Teresa Delgado Ureña,Dolores Isla,Lorena Bellido Hernández,José Luis Fírvida Pérez,Óscar Juan-Vidal,Bartomeu Massutí,Xabier Mielgo-Rubio,Ana Laura Ortega,Silvia Catot,Manuel Dómine, Corina Escoín-Pérez,Francisco García Navalón, Ignacio Gil-Bazo,Silvia Muñoz,Delvys Rodríguez-Abreu, Rosa María Villatoro Roldán,Guillermo Alonso-Jáudenes Curbera,Luis León-Mateos,Airam Padilla,Alfredo Paredes Lario,José Miguel Sánchez-Torres,Pilar Garrido

CLINICAL & TRANSLATIONAL ONCOLOGYno. 9 (2024): 2205-2216

引用0浏览0WOS引用

RET Fusion Testing in Patients with NSCLC: the RETING Study

JTO clinical and research reportsno. 4 (2024): 100653-100653

引用0浏览0WOS引用

Five-year Outcomes with First-Line (1L) Nivolumab + Ipilimumab + Chemotherapy (N + I + C) Vs C in Patients (pts) with Metastatic NSCLC (mnsclc) in CheckMate 9LA

Martin Reck,Tudor-Eliade Ciuleanu,Michael Schenker,Stephanie Bordenave,Manuel Cobo,Oscar Juan-Vidal,Niels Reinmuth,Eduardo Richardet,Enriqueta Felip,Juliana Menezes,Ying Cheng,Hideaki Mizutani,David Paul Carbone,Shun Lu,Tom John, Takekazu Aoyama,Javed Mahmood,Nan Hu,Laura Eccles,Luis G. Paz-Ares

Journal of Clinical Oncologyno. 16_suppl (2024): 8560-8560

引用0浏览0引用

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: the Randomized, Open-Label Phase III EVOKE-01 Study

Luis G. Paz-Ares,Oscar Juan-Vidal,Giannis S. Mountzios,Enriqueta Felip,Niels Reinmuth,Filippo de Marinis,Nicolas Girard,Vipul M. Patel,Takayuki Takahama,Scott P. Owen, Douglas M. Reznick,Firas B. Badin,Irfan Cicin,Sabeen Mekan, Riddhi Patel, Eric Zhang,Divyadeep Karumanchi,Marina Chiara Garassino

JOURNAL OF CLINICAL ONCOLOGYno. 24 (2024)

引用0浏览0WOS引用

European Society of Medical Oncology (ESMO) Guidelines for Oncogene-Addicted Metastatic Non-Small Cell Lung Cancer (NSCLC): a Personalized Treatment for Each Patient

Guillermo Suay,Francisco Aparisi,Oscar Juan-Vidal

Chinese clinical oncologyno. 3 (2024): 46-46

引用0浏览0WOS引用

Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small-Cell Lung Cancer: the Phase II BALTIC Study

Niels Reinmuth,Oscar Juan-Vidal, Dariusz Kowalski,Maciej Bryl,Anna Kryzhanivska,David Vicente,Zsolt Horváth,Gabriella Gálffy,Eszter Csánky,Zsolt Pápai Székely,Ihor Vynnychenko,Jon Armstrong,Tapashi Dalvi,Mingchao Xie,Sonia Iyer,Yashaswi Shrestha,Haiyi Jiang,Igor Bondarenko

crossref（2024）

引用0浏览0WOS引用

PP01.118 First-line Nivolumab (N) + Ipilimumab (I) + Chemotherapy (C) in Metastatic NSCLC (mnsclc): CheckMate 9LA 4-Year Clinical Update

Firas Badin,David P. Carbone,Tudor-Eliade Ciuleanu,Michael Schenker,Manuel Cobo-Dols,Stephanie Bordenave,Oscar Juan-Vidal,Juliana Menezes,Niels Reinmuth,Eduardo Richardet,Ying Cheng,Hideaki Mizutani,Luis G. Paz-Ares,Shun Lu,Thomas John, Xiaoqing Zhang, Nan Hu,David Balli,Vipul Baxi,Jaclyn Neely

Journal of Thoracic Oncologyno. 7 (2024): e51

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn